Ron Neumann – ISOPT Clinical 2018
Ron Neumann, Co-chair at ISOPT, introduces the 14th ISOPT Clinical meeting in Tel Aviv, Israel. This year’s meeting focussed on the latest innovations in drug and device therapies that are being introduced to ophthalmologists that are changing clinical practice.
Rolando & Melissa Toyos, ISOPT 2018 – IPL therapy and PRP eye drops for dry eye disease
Rolando and Melissa Toyos talk about their current research into intense pulse light (IPL) therapy for dry eye disease. IPL therapy is a light treatment applied to the skin to stimulate the meibomian glands to produce a better tear. The current study looks at the efficacy of IPL versus meibomian gland expression, and the results […]
Rolando & Melissa Toyos, ISOPT 2018 – The challenges of heathcare in the US
Rolando & Melissa Toyos discuss the ongoing healthcare challenges in the US and how they hope to make a difference. Keywords: Innovation, clinical, US healthcare, patient needs, ophthalmologists, Rand Paul, US Senator, healthcare spending, Medicaid, insurance, foreign policy
Francine Behar-Cohen, ISOPT 2018 – Challenges in the diagnosis of CNV
Francine Behar-Cohen discusses the treatment needs in CNV including effective anti-angiogenic drugs to inhibit the growth and survival of the neovessels and effective control of the scarring process. The introduction of OCT-A has proven useful in the identification of CNV but the real challenge is understanding when and when not to treat CNV, and which […]
Baruch Kuppermann, ISOPT 2018 – Challenges in the treatment of dry AMD
Baruch Kuppermann discusses the challenges of treating patients with dry AMD. Unlike wet AMD, which is responsive to anti-VEGF therapy, there are multiple challenges with wet AMD including the complement pathway and neuroprotection. There is an ongoing search into new ways of tracking wet AMD to find appropriate endpoints for clinical trials. KEYWORDS: wet AMD, […]
Baruch Kuppermann, ISOPT 2018 – Integrin peptide therapy in DME
Baruch Kuppermann discusses integrin peptide therapy and where it may fit within the current treatment regimen for patients with DME.
Irina Barequet, ISOPT 2018 – Treatment challenges in keratitis
Irina Barequet talks about her research into corneal crosslinking in bacterial keratitis and enzyme therapy for ocular infections.
Francesco Boscia, ISOPT 2018 – Anti-VEGF treatment regimens in DME
Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!